99 related articles for article (PubMed ID: 1635471)
1. Anti-oxidant therapy improves microvascular ultrastructure and perfusion in postischemic myocardium.
Maxwell L; Gavin J
Microvasc Res; 1992 May; 43(3):255-66. PubMed ID: 1635471
[TBL] [Abstract][Full Text] [Related]
2. The role of post-ischaemic reperfusion in the development of microvascular incompetence and ultrastructural damage in the myocardium.
Maxwell L; Gavin JB
Basic Res Cardiol; 1991; 86(6):544-53. PubMed ID: 1786035
[TBL] [Abstract][Full Text] [Related]
3. Endothelin antagonists diminish postischemic microvascular incompetence and necrosis in the heart.
Maxwell L; Harrison WR; Gavin JB
Microvasc Res; 2000 Mar; 59(2):204-12. PubMed ID: 10684726
[TBL] [Abstract][Full Text] [Related]
4. The contribution of ischaemia to the development of microvascular incompetence in the myocardium.
Maxwell L; Gavin JB
Cardiovasc Res; 1991 Jun; 25(6):491-5. PubMed ID: 1889062
[TBL] [Abstract][Full Text] [Related]
5. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
[TBL] [Abstract][Full Text] [Related]
6. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart.
Bernier M; Hearse DJ; Manning AS
Circ Res; 1986 Mar; 58(3):331-40. PubMed ID: 3087653
[TBL] [Abstract][Full Text] [Related]
7. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.
Ambrosio G; Zweier JL; Jacobus WE; Weisfeldt ML; Flaherty JT
Circulation; 1987 Oct; 76(4):906-15. PubMed ID: 2820615
[TBL] [Abstract][Full Text] [Related]
8. "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow.
Przyklenk K; Kloner RA
Circ Res; 1989 Jan; 64(1):86-96. PubMed ID: 2909304
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow.
Ambrosio G; Weisfeldt ML; Jacobus WE; Flaherty JT
Circulation; 1987 Jan; 75(1):282-91. PubMed ID: 3791610
[TBL] [Abstract][Full Text] [Related]
10. Ischemic preconditioning and superoxide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts.
Beresewicz A; Czarnowska E; Maczewski M
Mol Cell Biochem; 1998 Sep; 186(1-2):87-97. PubMed ID: 9774189
[TBL] [Abstract][Full Text] [Related]
11. Superoxide and hydrogen peroxide induce CD18-mediated adhesion in the postischemic heart.
Serrano CV; Mikhail EA; Wang P; Noble B; Kuppusamy P; Zweier JL
Biochim Biophys Acta; 1996 Aug; 1316(3):191-202. PubMed ID: 8781538
[TBL] [Abstract][Full Text] [Related]
12. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.
Kloner RA; Przyklenk K; Whittaker P
Circulation; 1989 Nov; 80(5):1115-27. PubMed ID: 2553296
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts.
Gambert S; Vergely C; Filomenko R; Moreau D; Bettaieb A; Opie LH; Rochette L
Mol Cell Biochem; 2006 Feb; 283(1-2):147-52. PubMed ID: 16444597
[TBL] [Abstract][Full Text] [Related]
14. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia.
Barsotti A; Di Napoli P; Taccardi AA; Spina R; Stuppia L; Palka G; Barbacane RC; De Caterina R; Conti P
Atherosclerosis; 2001 Mar; 155(1):53-9. PubMed ID: 11223426
[TBL] [Abstract][Full Text] [Related]
15. Effects of oxygen free radicals and scavengers on the cardiac extracellular collagen matrix during ischemia-reperfusion.
Lonn E; Factor SM; Van Hoeven KH; Wen WH; Zhao M; Dawood F; Liu P
Can J Cardiol; 1994 Mar; 10(2):203-13. PubMed ID: 8143221
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic cell death during ischemia/reperfusion and its attenuation by antioxidant therapy.
Galang N; Sasaki H; Maulik N
Toxicology; 2000 Aug; 148(2-3):111-8. PubMed ID: 10962129
[TBL] [Abstract][Full Text] [Related]
17. The transmural progression of the no-reflow phenomenon in globally ischemic hearts.
Sheppard AJ; Gavin JB
Basic Res Cardiol; 1988; 83(6):611-7. PubMed ID: 3223877
[TBL] [Abstract][Full Text] [Related]
18. Microvascular incompetence and the failure of hearts to recover contractile function after cardioplegia.
Choong YS; Gavin JB; Cottier DS; Edgar SG
Eur Heart J; 1995 Aug; 16(8):1140-6. PubMed ID: 8665978
[TBL] [Abstract][Full Text] [Related]
19. Direct measurement of myocardial free radical generation in an in vivo model: effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase.
Grill HP; Zweier JL; Kuppusamy P; Weisfeldt ML; Flaherty JT
J Am Coll Cardiol; 1992 Dec; 20(7):1604-11. PubMed ID: 1333498
[TBL] [Abstract][Full Text] [Related]
20. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury.
Ray PS; Maulik G; Cordis GA; Bertelli AA; Bertelli A; Das DK
Free Radic Biol Med; 1999 Jul; 27(1-2):160-9. PubMed ID: 10443932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
